scholarly article | Q13442814 |
P2093 | author name string | G Yancey Gillespie | |
C Ryan Miller | |||
Donald J Buchsbaum | |||
Christopher R Williams | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytosine | Q178425 |
gene therapy | Q213901 | ||
fluorouracil | Q238512 | ||
P304 | page(s) | 773-780 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas | |
P478 | volume | 62 |
Q35537301 | Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein |
Q36609637 | Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts |
Q38660825 | All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic. |
Q37251338 | Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase |
Q36474463 | Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model |
Q35696378 | Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector |
Q48229251 | Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma. |
Q42785240 | Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery |
Q27026937 | Contemporary murine models in preclinical astrocytoma drug development |
Q30545759 | Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis |
Q36220635 | Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression |
Q64984612 | Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model. |
Q42135456 | Gene- and viral-based therapies for brain tumors |
Q50905634 | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells. |
Q35115061 | Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene |
Q39431566 | Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice. |
Q40413196 | Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells |
Q40305636 | Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters |
Q91663805 | Learning a Latent Space of Highly Multidimensional Cancer Data |
Q38893603 | Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy |
Q38963855 | Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice |
Q33985663 | Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders |
Q27006099 | Novel delivery strategies for glioblastoma |
Q35077747 | Oncolytic adenoviruses: A thorny path to glioma cure |
Q90420565 | Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy |
Q34389909 | Photochemical internalization-mediated nonviral gene transfection: polyamine core-shell nanoparticles as gene carrier |
Q36297034 | Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy |
Q24792836 | Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy) |
Q36602123 | Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types |
Q37526280 | Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors |
Q37192753 | Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells |
Q36493746 | Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine |
Q34468009 | Targeted enzyme prodrug therapy for metastatic prostate cancer - a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase |
Q36527593 | The art of gene therapy for glioma: a review of the challenging road to the bedside |
Q36640056 | Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review). |
Q40760304 | Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models |
Search more.